Gullik Håkan Wickholm
Director/Board Member at Beactica Therapeutics AB
Gullik Håkan Wickholm active positions
| Companies | Position | Start | End |
|---|---|---|---|
Beactica Therapeutics AB
 Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Director/Board Member | 2017-12-31 | - |
| GHW Consulting AB | Director/Board Member | - | - |
Career history of Gullik Håkan Wickholm
Former positions of Gullik Håkan Wickholm
| Companies | Position | Start | End |
|---|---|---|---|
| AstraZeneca AS | Corporate Officer/Principal | - | - |
| GENOVIS AB | Director/Board Member | 2018-12-31 | - |
| LYTIX BIOPHARMA | Chief Executive Officer | 2013-12-31 | 2017-09-06 |
| Corporate Officer/Principal | 2017-09-06 | - |
Training of Gullik Håkan Wickholm
| University of Uppsala | Undergraduate Degree |
Statistics
International
| Sweden | 5 |
| Norway | 3 |
Operational
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Distribution Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| LYTIX BIOPHARMA | Health Technology |
| GENOVIS AB | Health Technology |
| Private companies | 3 |
|---|---|
| AstraZeneca AS | |
Beactica Therapeutics AB
Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Distribution Services |
| GHW Consulting AB |
